[Recommendations to otolaryngologists for patients with antituberculotic chemotherapy (author's transl)].
With long-time antituberculotic chemotherapy aminoglycosid-antibiotics (Streptomycin, Neomycin, Kanamycin, Gentamycin) and polypeptid-antibiotics (Polymyxin B, Viomycin, Capreomycin) will endanger the nervus statoacusticus. After discussing manner and frequency of possible troubles recommendations are given to the ENT-physician, how to minimize the damage for the cochleovestibular system.
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003389:Cranial Nerve Diseases / Q000139:chemically induced; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D007759:Labyrinth Diseases / Q000139:chemically induced; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D000995:Antitubercular Agents
Uberwachungsrichtlinien für den HNO-Arzt bei Chemotherapie der Tuberkulose.